首页|期刊导航|中国临床药理学与治疗学|亚麻醉剂量艾司氯胺酮对老年髋关节置换术患者血清基质金属蛋白酶-9及术后谵妄的影响

亚麻醉剂量艾司氯胺酮对老年髋关节置换术患者血清基质金属蛋白酶-9及术后谵妄的影响OA

Effects of sub-anesthetic dose esketamine on serum matrix metallo-proteinase-9 and postoperative delirium in elderly patients undergo-ing hip replacement

中文摘要英文摘要

目的:评估亚麻醉剂量艾司氯胺酮对老年髋关节置换术患者血清基质金属蛋白酶-9(MMP-9)及术后谵妄(POD)的影响.方法:招募 2024年 2月至 2025年 3月于本院择期全身麻醉下行髋关节置换术的老年患者 110例,年龄65~79岁,随机分为艾司氯胺酮组(E 组,n=55)和对照组(C 组,n=55).E 组患者给予艾司氯胺酮(负荷剂量 0.2 mg/kg,随后以 0.1 mg·kg-1·h-1的速度持续输注),而 C 组患者给予等容量的生理盐水(负荷剂量0.2 mL/kg,随后以0.1 mL·kg-1·h-1的速度持续输注).术后 3 d 采用重症监护室(ICU)意识障碍评估法(CAM-ICU)评估 POD.于术前、术后 1 d 及术后 3 d 通过静脉采血检测MMP-9、白细胞介素 6(IL-6)和白细胞介素1β(IL-1β)的血清浓度.使用 15项恢复质量问卷(QoR-15)在术后 1 d 和 2 d 评估恢复质量并记录首次下地活动时间及住院时间.结果:与C 组比较,E 组 POD 发生率显著降低(9.1%vs.23.6%,χ2=4.251,P=0.039),且 POD 严重程度[(3.1±1.1)vs.(4.2±1.6)分,t=4.201,P<0.001]和持续时长[(1.1±0.7)vs.(2.2±0.9)d,t=7.155,P<0.001]均显著改善.术后 1 d 和 3 d,E 组血清MMP-9、IL-6及 IL-1β 浓度均显著低于 C 组(P 均<0.001).与 C 组比较,E 组 QoR-15评分显著更高[术后 1 d:(114.1±7.4)vs.(91.3±5.3)分;术后 2 d:(126.1±8.5)vs.(103.2±6.3)分,P 均<0.001),首次下地活动时间更短[(27.6±3.7)vs.(31.4±3.3)h,P<0.001].两组术中及术后不良事件总发生率均相近(P>0.05).结论:亚麻醉剂量艾司氯胺酮可显著降低老年髋关节置换术患者 POD 发生率、血清 MMP-9及 IL-6、IL-1β 水平,改善术后恢复质量,且不增加围术期不良事件风险,为优化老年患者麻醉管理提供了有效策略.

AIM:To evaluate the effects of sub-anesthetic dose of esketamine on serum matrix metalloproteinase-9(MMP-9)and postoperative delirium(POD)in elderly patients undergoing hip replacement.METHODS:From February 2024 to March 2025,110 elderly patients aged 65-79 years undergoing elective hip replacement under general anesthesia in our hospital were randomly divided into esketamine group(group E,n=55)and control group(group C,n=55).Patients in group E were giv-en esketamine(loading dose 0.2 mg/kg,followed by continuous infusion at a rate of 0.1 mg·kg-1·h-1),while patients in group C were given an equal vol-ume of normal saline(loading dose 0.2 mL/kg,fol-lowed by continuous infusion at a rate of 0.1 mL·kg-1·h-1).POD was assessed by the confusion as-sessment method for the intensive care unit(CAM-ICU)at 3 days after operation.The serum concen-trations of MMP-9,interleukin-6(IL-6)and inter-leukin-1β(IL-1β)were detected by venous blood sampling before operation,1 d and 3 d after opera-tion.The quality of recovery was assessed using the 15-item quality of recovery questionnaire(QoR-15)at 1 and 2 days after surgery,and the time to first ambulation and length of hospital stay were record-ed.RESULTS:Compared with Group C,Group E showed a significantly lower incidence of POD(9.1%vs.23.6%,χ2=4.251,P=0.039),along with reduced severity(3.1±1.1 vs.4.2±1.6 score,t=4.201,P<0.001)and shorter duration of POD(1.1±0.7 vs.2.2±0.9 days,t=7.155,P<0.001).Serum concentra-tions of MMP-9,IL-6,and IL-1β in Group E were sig-nificantly lower than those in Group C at postopera-tive day 1 and day 3(all P<0.001).Compared to Group C,Group E demonstrated significantly higher QoR-15 scores[postoperative day 1:(114.1±7.4)vs.(91.3±5.3)score;postoperative day 2:(126.1±8.5)vs.(103.2±6.3)score,both P<0.001]and earlier am-bulation time(27.6±3.7 vs.31.4±3.3 h,P<0.001).The total incidence of intraoperative and postoper-ative adverse events was similar between the two groups(P>0.05).CONCLUSION:Subanesthetic-dose esketamine significantly reduces the incidence of POD and serum levels of MMP-9,IL-6,and IL-1β,im-proves postoperative recovery quality,and does not increase perioperative adverse events in elderly pa-tients undergoing hip replacement,providing an ef-fective strategy for optimizing anesthesia manage-ment in geriatric populations.

靳广丽;苏丽莎;王利品;王其敏

郑州大学附属郑州中心医院麻醉与围手术期医学科,郑州 450000,河南郑州大学附属郑州中心医院麻醉与围手术期医学科,郑州 450000,河南郑州大学附属郑州中心医院麻醉与围手术期医学科,郑州 450000,河南郑州大学附属郑州中心医院麻醉与围手术期医学科,郑州 450000,河南

医药卫生

艾司氯胺酮基质金属蛋白酶-9谵妄骨科手术老年

esketaminematrix metallopro-teinase-9postoperative deliriumorthopedic surgeryelderly

《中国临床药理学与治疗学》 2026 (5)

631-638,8

河南省医学科技攻关计划省部共建青年项目(202303028)

10.12092/j.issn.1009-2501.2026.05.007

评论